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ABSTRACT
Genome sequencing plays a key role in understanding the genetic diversity of
Mycobacterium tuberculosis (M.tb). The genotype-specific character of M. tb con-
tributes to tuberculosis severity and emergence of drug resistance. Strains of M. tb
complex can be classified into seven lineages. The Nonthaburi (NB) genotype,
belonging to the Indo-Oceanic lineage (lineage 1), has a unique spoligotype and IS6110-
RFLP pattern but has not previously undergone a detailed whole genome analysis.
In addition, there is not much information available on the whole genome analysis
of M. tb isolates from tuberculous meningitis (TBM) patients in public databases.
Isolates CSF3053, 46-5069 and 43-13838 of NB genotype were obtained from the
cerebrospinal fluids of TBM Thai patients in Siriraj Hospital, Bangkok. The whole
genomes were subjected to high throughput sequencing. The sequence data of each
isolate were assembled into draft genome. The sequences were also aligned to reference
genome, to determine genomic variations. Single nucleotide polymorphisms (SNPs)
were obtained and grouped according to the functions of the genes containing them.
They were compared with SNPs from 1,601 genomes, representing the seven lineages of
M. tb complex, to determine the uniqueness of NB genotype. Susceptibility to first-line,
second-line and other antituberculosis drugs were determined and related to the SNPs
previously reported in drug-resistant related genes. The assembled genomes have an
average size of 4,364,461 bp, 4,154 genes, 48 RNAs and 64 pseudogenes. A 500 base pairs
deletion, which includes ppe50, was found in all isolates. RD239, specific formembers of
Indo Oceanic lineage, and RD147c were identified. A total of 2,202 SNPs were common
How to cite this article Coker et al. (2016), Genetic signatures ofMycobacterium tuberculosis Nonthaburi genotype revealed by whole
genome analysis of isolates from tuberculous meningitis patients in Thailand. PeerJ 4:e1905; DOI 10.7717/peerj.1905
to the isolates and used to classify the NB strains as members of sublineage 1.2.1.
Compared with 1,601 genomes from the seven lineages of M. tb complex, mutation
G2342203C was found novel to the isolates in this study. Three mutations (T28910C,
C1180580T and C152178T) were found only in Thai NB isolates, including isolates
from previous study. Although drug susceptibility tests indicated pan-susceptibility,
non-synonymous SNPs previously reported to be associated with resistance to anti-
tuberculous drugs; isoniazid, ethambutol, and ethionamide were identified in all the
isolates. Non-synonymous SNPswere found in virulence genes such as the genes playing
roles in apoptosis inhibition and phagosome arrest. We also report polymorphisms in
essential genes, efflux pumps associated genes and genes with known epitopes. The
analysis of the TBM isolates and the availability of the variations obtained will provide
additional resources for global comparison of isolates frompulmonary tuberculosis and
TBM. It will also contribute to the richness of genomic databases towards the prediction
of antibiotic resistance, level of virulence and of origin of infection.
Subjects Bioinformatics, Genomics, Microbiology, Infectious Diseases
Keywords Draft genome,M. tuberculosis Nonthaburi genotype, Meningitis, Genetic signatures,
Thailand, Whole genome sequence
INTRODUCTION
Tuberculosis (TB) remains a global threat despite efforts targeted towards its control.
With recent advances in next generation sequencing, the analysis of bacterial whole
genome sequences has contributed significantly to the understanding of virulence factors
and antibiotic resistance of pathogenic bacteria (Koser et al., 2013; Leopold et al., 2014).
Currently, there are software tools and databases that are used for predicting bacterial
genotype, lineages and drug resistance profile from mycobacterial whole genome sequence
data (Benavente et al., 2015; Coll et al., 2015). Availability of more whole genome data
(processed and unprocessed), especially from genotypes not currently available, will
contribute immensely to the profiling of pathogens.
Although tuberculosis is a curable disease, 9.0 million new cases and 1.5 million
TB deaths were recorded in 2013 (Zumla et al., 2015). This is due in part to incomplete
understanding of the variations that contribute to the pathogenesis and antibiotic resistance
ofMycobacterium tuberculosis. There are two broad types of clinical TB disease; pulmonary
(PTB) in which the site of infection is the lung and extra-pulmonary, including the more
severe tuberculous meningitis (TBM), in which the bacteria cross the blood brain barrier
to get into the cerebrospinal fluid (CSF) of the patient. The morbidity and mortality rate
of TBM is higher than PTB (Thwaites, van Toorn & Schoeman, 2013). The genotype of the
infecting mycobacterium has been shown to be one of the factors that contribute to the
severity of the disease and can play a role in emergence of drug resistance, susceptibility
to TBM, host response and in transmissibility (Ford et al., 2013; Lopez et al., 2003; Nahid et
al., 2010; Thwaites et al., 2008). However the genetic factors that determine the association
of different lineages of mycobacteria with different level of disease severity remain largely
unknown.
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There have been controversies in associating specific genotypes with morbidity or
mortality from TB. A study in Thailand associated the modern Beijing genotype with a
more severe disease progression when compared with other lineages (Faksri et al., 2011).
However, in a study conducted in HIV patients in Vietnam, modern Beijing genotype had
lower mortality rates than those infected with other lineages (Tho et al., 2012). Comparing
strains isolated from TBM across genotypes on a whole genome scale may provide better
understanding of factors that contribute to the severity of the disease.
IS6110 based restriction fragment length polymorphism (RFLP) is an internationally
recognized method for genotyping mycobacteria (Thierry et al., 1990; van Embden et al.,
1993). Nonthaburi strains ofM. tuberculosis were first identified in Thailand by its IS6110-
RFLP patterns, usually containing 9-14 bands. Subsequent spoligotyping revealed that the
Nonthaburi type has a spoligotype octal code 674000003413771 specifying the East-Asian
India 2 Nonthaburi (EAI2-Nonthaburi) genotype (Palittapongarnpim et al., 1997). It has
been reported in lower percentages frommany countries such as the Netherlands, Australia,
USA, Sweden, Saudi Arabia, Tunisia, and Taiwan. However, the origin of the isolates is
likely to be South East Asia, as more isolates are from countries such as Indonesia, Laos
PDR, Vietnam, Cambodia, Philippines and Thailand (Demay et al., 2012).
As of this date, only relatively little information is available on the genetic characteristics
of the Nonthaburi strains. Three Nonthaburi strains were isolated from the CSF samples of
TBMpatients at Siriraj Hospital, Mahidol University, Thailand. For a deeper understanding
of the characteristics of these isolates, genome-wide scale analysis and drug susceptibility
pattern to anti-tuberculosis drugs were performed and compared to the reference strainM.
tuberculosisH37Rv (NC_000962.3). The single nucleotide polymorphism (SNPs) common
to the isolates were compared with SNPs from 1,601 genomes from the 7 different lineages
and various sublineages ofM. tuberculosis complex (MTBC). The whole genome sequence
of the isolates were assembled into draft genomes, annotated and have been deposited into
NCBI database for public access. Prior to our study, there was no complete or draft genome
belonging to the Nonthaburi genotype ofM. tuberculosis in the database.
METHODS
Selection of strains
Three isolates, CSF3053, 46-5069 and 43-13838, identified to belong to Nonthaburi
genotype by IS6110-RFLP, were selected from the stock of samples collected from the CSF
of TBMpatients at theDrug Resistant Tuberculosis Research Fund Laboratory, Department
of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
Genomic DNA extraction
Stock culture of selected strains, stored at−70 ◦C inMH79 broth containing 15% glycerol,
were subcultured on Loewenstein-Jensenmedium and incubated for 4weeks at 37 ◦C.DNA
extraction was carried out using cetyltrimethylammonium bromide (CTAB)-lysozyme
enzymatic method as earlier described (Larsen et al., 2007).
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Spoligotyping
Spacer oligonucleotide typing, a polymerase chain reaction (PCR) based method
used in typing M. tuberculosis was performed following the methods earlier described
(Gori et al., 2005).
Whole genome sequencing and analysis
Genomic DNA samples isolated from the three isolates were sequenced at Macrogen Inc.,
Seoul, South Korea on the HiSeq 2000 platform with insert size of 300 bp (Illumina, San
Diego, CA, USA) yielding 100 bp paired end reads. The qualities of the sequences were
assessed with FastQC software (www.bioinformatics.babraham.ac.uk/projects/fastqc) to
determine the parameters used for trimming. Bases with quality of less than 5, reads with
average of quality less than 20 for every four bases, and reads with lengths that are less
than 45 bases were discarded using Trimmomatic software (Bolger, Lohse & Usadel, 2014)
(version 0.33). The trimmed sequences were aligned to the reference strainM. tuberculosis
H37Rv (NC_000962.3) using the short reads aligner, Bowtie2 (version 2.2.0) (Langmead
& Salzberg, 2012). The genomic coverage was estimated using Bedtools (version 2.18)
(Quinlan & Hall, 2010). The fold coverage is estimated as the number of reads supporting
a particular nucleotide position on the genome. Variant calling was performed on the
aligned sequences using the Genome Analysis Tool Kit (GATK) (version 3.3) haplotype
caller (McKenna et al., 2010) with minimum calling confidence threshold set at phred
score 30. Point allelic variation at any position within the genome when compared with the
reference H37Rv genome (NC_000962.3) is considered a single nucleotide polymorphism
(SNP).
SnpEFF (Cingolani et al., 2012) (version 4.0) software was used to annotate the
SNPs. The SNPs were filtered using standard hard filtering parameters according to
GATK Best Practices Recommendations (DePristo et al., 2011; Van der Auwera et al.,
2013). Variants with QualByDepth <2.0, FisherStrand >60, RMSMapping quality <40,
MappingQualityRankSumTest <−12.5 and ReadPosRankSumTest <−8 were filtered. All
SNPs were confirmed using Integrated Genomic Viewer (IGV) (James et al., 2011) (version
2.0). The SNPs were further grouped according to the functions of the genes in which they
were found in the genomewhen compared to the reference genomeH37Rv (NC_000962.3).
We evaluated SNPs in groups of genes considered to be essential, drug resistance related,
virulence related, contain known epitopes and associated with efflux pumps.
The Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank
under the accession numbers LGCH00000000, LGCG00000000 and LGCF00000000. The
versions described in this paper are LGCH01000000, LGCG01000000 and LGCF01000000
for CSF3053, 46-5069 and 43-13838 respectively. The raw sequences have been deposited to
the short read archive (SRA) of NCBI under accession numbers SRX1094547, SRX1094546
and SRX1094545 for isolates CSF3053, 46-5069 and 43-13838 respectively.
Determination of principle genetic group, lineage and sequence type
Nucleotide alleles at positions 7585 and 2154724 were investigated to determine the
principal genetic group of the isolates as earlier defined (Sreevatsan et al., 1997). To
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determine the lineage of the isolates, SNPs specific to different lineages as earlier reported
(Coll et al., 2014b) were investigated.
Draft genome assembly
The paired-end raw reads of the isolates were assembled into draft genomes by using the de
novo assembly algorithm of CLC GenomicsWorkbench (version 7.5) which works by using
a de Bruijn graph (http://www.clcbio.com/). The minimum contig output was set at 200 bp
long. Annotation of the draft genomewas performed by Rapid Annotation using Subsystem
Technology (RAST) (http://www.nmpdr.org/) and by NCBI Prokaryotic Genome
Annotation Pipeline (PGAP) (http://www.ncbi.nlm.nih.gov/genome/annotation_prok/).
Comparison of Nonthaburi isolates with isolates from other lineages
The SNPs that are common to the three isolates were compared with 92,000 SNPs from
1,601 genomes ofMTBC previously reported (Coll et al., 2014a) (http://pathogenseq.lshtm.
ac.uk/phytblive/index.php). These include 121, 390, 189, 856, 17, 11, and 6 genomes from
lineages 1, 2, 3, 4, 5, 6, and 7 respectively. Eleven samples fromM. bovis were also included.
Large sequence polymorphism determination
Regions of differences when compared with reference strain H37Rv (NC_000926.3)
were determined by using the indel and structural variants determination tool of CLC
Genomics Workbench (version 7.5) (http://www.clcbio.com) and Bedtools (version
2.18) (Quinlan & Hall, 2010). The regions of deletions were confirmed with PCR using
primers CF (CATCCGCACCGAACCTGTAA) and CR (AACCGTTCACGACAAGCAAC),
AF (GCCCAACCTGATTGGTTTCG) and AR (CAAACGCTCGCCATGATCTC), BF
(TCGACTGCCATACAACCTGC) and BR (ACTTCCGGTGGTAACAGTGC) respectively
for RD239, RD147c and newly identified deletion of 500 bp between 3501224-3501724 (M.
tuberculosis H37Rv (NC_000962.3 genome numbering). The reactions were performed
with initial denaturation at 94 ◦C and 30 cycles of denaturation for 1 min, annealing of
primers at 60 ◦C for 1 min and extension with platinum TaqDNA polymerase for 1 min at
68 ◦C. Final extensions were performed at 68 ◦C for 10 min. The reactions were performed
as recommended by the manufacturer of the DNA polymerase.
Drug susceptibility testing
The susceptibility of the isolates to first line drugs and other second-line anti-tuberculosis
drugs was investigated using the standard agar proportion method (Larsen et al., 2007).
The drug concentrations used in the test comprise 0.2 mg/l isoniazid, 1.0 mg/l rifampicin,
2.0 mg/l streptomycin, 5.0 mg/l ethambutol, 1.0 mg/l linezolid, 6.0 mg/l amikacin, 5.0 mg/l
ethionamide, 2.0 mg/l paraaminosalycic acid, 2.0 mg/ml ofloxacin, 2.0 mg/l moxifloxacin,
2.0 mg/l gatifloxacin, 1.0 mg/ml sitafloxacin, 6.0 mg/l kanamycin, 2.0 mg/l ciprofloxacin,
2.0 mg/l levofloxacin, and 3.0 mg/l clarithromycin. Growth equal to or more than 1%
on drug containing media compared to drug free media was recorded as drug resistance.
The phenotypic drug testing was performed on the initial isolates from the patients and
repeated on the stock cultures.
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Ethical approval
The study was approved by the Institutional review board (IRB) of Faculty of Medicine
Siriraj Hospital, Mahidol University SiEC No. 152/2549.
RESULTS AND DISCUSSION
For the three isolates CSF3053, 46-5069 and 43-13838, an average of 99.1% of raw reads
mapped to the reference genome. On the average, 99.8% of the reference was covered to
at least 1-fold coverage. The depth across all the positions covered by the reads was about
1,056-fold on the average (Table 1).
Genome assembly
The sequences of the isolates were assembled and annotated as described in Methods. 159
contigs with N50 of 69,028, 173 contigs with N50 of 63,852, and 177 contigs with N50 of
63,019 contigs were obtained for CSF3053, 43-5069 and 46-13838 respectively. All isolates
have 65.5 % guanine/cytosine (GC) content, typical of mycobacteria. The draft genomes
have an average size of 4,364,461 bp, 4,154 genes, 48 rRNAs and 64 pseudogenes. Details
of the assembly and annotation are shown in Table 1.
Single nucleotide polymorphisms
Point allelic variations at any positionwithin the genomewhen comparedwith the reference
H37Rv genome (NC_000962.3) were investigated.
In total, 2,202 positions were found to have similar allelic changes (SNPs) in all isolates
as shown in Fig. 1. 1,963 are in coding regions (754 synonymous, 1209 (61.6%) non
synonymous) and 239 are intergenic. In this study, CSF3053, 46-5069 and 43-13838 have
10, 7 and 49 unique SNPs respectively. 43-13838 and CSF3053 have 23 SNPs in common,
CSF3053 and 46-5069 have 99 SNPs in common, while 43-13838 and 46-5069 have 7
SNPs in common. Using the SNPs, the isolates were found to belong to lineage 1 with the
presence of allele C/A and G/C at positions 2154724 and 7585 resulting in katG R463L and
gyrA S95T respectively (Sreevatsan et al., 1997). Using a recently developed SNP barcode
(Coll et al., 2014a), the isolates were found to be specific to Indo Oceanic lineage 1.2.1,
with nucleotide changes G/A at position 615938, C/A at position 3479545, G/C at position
4244420 and G/C at position 9260.
The 2,202 SNPs that were found to be common to the isolates in this study were
compared with 92,000 SNPs from 1,601 genomes of MTBC that were analyzed previously.
These include 121, 390, 189, 856, 17, 11, and 6 genomes from lineages 1, 2, 3, 4, 5, 6, and
7, respectively. Eleven samples from M. bovis were also included (Coll et al., 2014a). The
common SNPs were used to position the strains on a phylogenetic tree compared to other
strains and lineages of MTBC as shown in Fig. S1. Nucleotide change G/C at position
2342203 was found only in the isolates in this study when compared with the 1,601 MTBC
genomes. There is evidence from macrophage systems that strain-to-strain variability
affects phenotypic outcomes (McEvoy et al., 2012). Phylogeographic strain variation may
therefore have considerable effect on the development of new diagnostic tools, vaccines
and drugs.
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Table 1 Statistics of whole genome sequencing, genome assembly and annotation.Gross statistics of the whole genome sequence data, mapping of reads, assembly of
draft genome and annotation for isolates CSF-3053, 46-5069 and 43-13838. Length of reference genome (M. tuberculosisH37Rv, NC_000962.3) is 4,411,532 base pairs.
Isolate Total reads % of reads
mapped to
reference
% of
Reference
covered
Number
of contigs
N50 Fold coverage
of positions in
the genome
GC content
(%)
Number of
predicted
Genes
No. of
predicted
RNA genes
No. of
predicted
pseudo genes
CSF-3053 50,004,564 99.96 99.78 159 69,028 1329.0 65.5 4153 48 62
46-5069 44,478,206 98.67 99.82 173 63,852 920 65.5 4159 48 63
43-13838 40,767,970 98.69 99.80 177 63,019 920 65.5 4150 48 67
Notes.
GC, guanine/cytocine.
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Figure 1 Distribution of single nucleotide polymorphisms in isolates CSF3053, 46-5069 and 43-13838.
Venn diagram showing the distribution of the single nucleotide polymorphisms (SNPs) observed in iso-
lates CSF-3053 (blue), 46-5069 (red) and 43-13838 (yellow). CSF3053, 46-5069 and 43-13838 have 10, 7
and 49 unique SNPs respectively. 43-13838 and CSF3053 have 23 SNPs in common, CSF3053 and 46-5069
have 99 SNPs in common, while 43-13838 and 46-5069 have 14 SNPs in common. 2,202 SNPs are com-
mon to all isolates.
SNP C/T at position 3378828 was reported to be unique to members of lineage 1 (Coll
et al., 2014a). Although this SNP was found in many genomes belonging to lineage 1, we
found out that it was absent in the three isolates in this study and in 6 other Nonthaburi
isolates from Thailand and the Netherlands used in previous studies which are grouped
under lineage 1. This indicates that the allele change at this position may be specific only
to a sub-branch of lineage 1. Synonymous SNP T/C at position 28910, non-synonymous
SNP C/T at position 152178 resulting in Thr344Ile in pepA gene and intergenic SNP C/T
at position 1180580 were found only in Nonthaburi isolates from Thailand. They were not
found in any genome belonging to lineages 2, 3, 4, 5, 6 and 7. Within lineage 1, these SNPs
were found only in Thai Nonthaburi isolates, from previous study (Coll et al., 2014a), and
the isolates in this study. They were however absent in the Nonthaburi genotype isolates
from the Netherlands. pepA gene is a probable serine protease with the exact function
unknown. It is in the intermediary metabolism and respiration functional category. Its
mRNA was found to be upregulated after 96 h of starvation (Betts et al., 2002), suggesting
its role in the adaptation of mycobacteria to extreme conditions. The association of the
SNPs at these positions with Thailand warrants further investigation.
Large sequence polymorphism
Region of difference RD239 that is specific to lineage 1 of MTBC and previously reported
RD147c, not specific to lineage 1, were found in all the three isolates. In addition, a region
of deletion of 500 bp between 3501224-3501724 (M. tuberculosis H37Rv (NC_000962.3
genome numbering) comprising Rv3135 (ppe50), was observed in all isolates. The details
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Table 2 Regions of deletion and affected open reading frames found in isolates CSF-3053, 46-5069 and
43-13838. All regions were confirmed by PCR reaction as described in methods.
Region in reference genome
(H37Rv, NC_000962.3)
Length Region of difference Open reading frame
(ORF) affected
1718912–1721213 2302 RD147c Rv1526c
Rv1525 (wbbL2)
Rv1526c
3501225–3501723 499 This study Rv3135
4092082–4092921 840 RD239 Rv3651
of the deletions as well as the affected open reading frames are shown in Table 2. The
deletions were confirmed with PCR (see Figs. S2, S3 and S4). The PE-PPE protein class,
while not well characterized, represents the third most abundant category of mycobacterial
proteins and showed the most consistent expression during infection (Kruh et al., 2010).
Although PPE50 has a yet unknown function, it was listed among promising therapeutic
target in tuberculosis treatment based on its expression, and homology to human and other
microbial proteins (Raman, Yeturu & Chandra, 2008). The deletion of this gene may be a
means of evading recognition by the host immune system.
Deletions have been shown to have a wide range of effects on M. tuberculosis including
association with an increased probability of transmission (Tsolaki et al., 2004).
Polymorphisms in drug resistance associated genes
Despite being isolated from patients with severe form of tuberculosis, drug susceptibility
tests results show that the three isolates are susceptible to first line drugs; isoniazid,
rifampicin, ethambutol and streptomycin, and to quinolones: ciprofloxacin, ofloxacin,
gatifloxacin, moxifloxacin, levofloxacin, and sitafloxacin. They were also found to be
susceptible to linezolid, amikacin, ethionamide, paraaminosalicylic acid, kanamycin and
clarithromycin.
However, 37 SNPs were found in drug-resistant related genes reported in TBdream
database and other earlier published reports (Sandgren et al., 2009). Nineteen are
synonymous while 18 are non synonymous. Non synonymous mutations Gly312Ser
of kasA gene and Ile73Thr in efpA were previously reported to be associated with isoniazid
resistance (Mdluli et al., 1998; Ramaswamy et al., 2003), but were found in our isolates.
Association between these mutations and resistance to isoniazid needs to be confirmed.
iniA gene and Rv1592c were reported to be associated with tolerance to isoniazid (Colangeli
et al., 2005; Ramaswamy et al., 2003). In our analysis, mutations His481Gln in iniA gene
and Ile322Val in Rv1592c were found. These positions may not be associated with the
supposed roles of these genes in isoniazid resistance.
Polymorphism exists at position 237 of nudC in M. tuberculosis isolates (Wang et al.,
2011). In particular, the amino acid change Gln237Pro in nudC is found in the Indo
Oceanic and West African lineages. It was demonstrated to prevent dimer formation and
results in the loss of activity of the enzyme. It was also shown to degrade the active forms
of isoniazid and ethionamide (Wang et al., 2011). We however found this codon change in
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all isolates in this study. This suggests the non-involvement of the amino acid change at
this position in resistance to both drugs.
Mutations Cys110Tyr in embR, Thr270Ile and Asn394Asp in embC, Pro913Ser in embA
and Glu378Ala in embB, were previously reported to be involved in ethambutol resistance
(Ramaswamy et al., 2000; Srivastava et al., 2009). However, these mutations were found
in this study. Mutation Ser257Pro in rmlD was suspected to be involved in isoniazid and
ethambutol resistance (Ramaswamy et al., 2000). This was however found in all isolates
considered in this study. Mutations Glu21Gln in gyrA, Ile322Val in Rv1592c, Arg463Leu
in katG, and Arg93Leu in cycA were found to be common to the isolates in this study.
They have also been reported to be common to pan-susceptible and drug-resistant M.
tuberculosis sequence type 10 Beijing isolates (Regmi et al., 2015). Our results confirm that
these mutations are polymorphic rather than being involved in drug resistance. The details
of the synonymous and non-synonymous SNPs found in drug-resistant related genes and
the predicted protein variation effects are shown in Table 3.
Polymorphisms in virulence genes, eﬄux pump related genes, and
essential genes
Oftentimes, mutations provide selective advantage to an organism in a particular
environment. Some non-synonymousmutations in rpoC gene have been shown to result in
higher competitiveness in vitro and have higher fitness in vivo evidenced by their prevalence
across patient populations (Comas et al., 2012). In this study, we found Ala172Valmutation
in rpoC gene in all isolates.
We also sought to determine polymorphisms in genes that play important roles in the
survival and pathogenesis of M. tuberculosis. Of particular interest are the genes that are
involved in the evasion of the host immune system. SNPs in 37 mycobacteria virulence
related genes were found to be common to the isolates. Twenty nine of the SNPs are
non-synonymous. Polyketide synthases (PKs) are group of genes involved in the synthesis
of polyketides which are structurally complex compounds produced by organisms for
survival advantage. Some mycobacteria PKs genes such as pks15, pks1, pks10, pks12, pks5,
and pks7 are known to be involved in virulence (Reed et al., 2004; Rousseau et al., 2003;
Sirakova et al., 2003; Tsenova et al., 2005). Insertion of 7 base pairs was found in pks15/1
junction in all isolates. The presence of the 7 base pair insertion leads to a frame shift that
results in the loss of stop codon of pks15. This results in a continuous transcription of
pks15 and pks1. This was previously associated with the more virulent phenotype of the
modern Beijing family, but such claim has since been refuted as it can be found across the
seven lineages. The implication of the insertion needs further experiments to understand.
Two mutations Ile474Met and Thr604Ala were found in nuoG gene. nuoG is a probable
NADH dehydrogenase, reported to be involved in apoptosis inhibition (Velmurugan et al.,
2007). Mutation Arg463Leu was found in katG, a gene previously implicated in inhibiting
antimicrobial effectors of the macrophage (Ng et al., 2004). Protein kinases such as pknD
and pknG are important virulent factors ofM. tuberculosis. pknD has been reported to play
a role in the infection of the host’s central nervous system by M. tuberculosis (Be, Bishai &
Jain, 2012; Cowley et al., 2004). Gln472Pro mutation in pknD was found in all isolates. virS
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Table 3 Common SNPs found in drug resistance related genes in isolates CSF-3053, 46-5069 and 43-13838. The reference genome positions,
nucleotide change, amino acid change and effect of single nucleotide polymorphisms in drug resistance related genes that are common to isolates
CSF3053, 46-5069 and 43-13838. The protein variation was determined by Protein Variation Effect Analyzer (PROVEAN), a web based protein vari-
ation analysis tool (Choi et al., 2012).
Position in
reference
genome
(H37Rv,
NC_000962.3)
Nucleotide
change
Amino acid
change
Protein
variation
effect
Gene Associated drug References
6112 G>C Met291Ile Deleterious gyrB Quinolones Guillemin, Jarlier & Cambau (1998)
7362 G>C Glu21Gln Neutral gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
7585 G>C Ser95Thr Neutral gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
and Kapur et al. (1995)
8452 C>T Ala384Val Deleterious gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
9143 T>C Ile614Ile gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
9260 G>C Leu653Leu gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
9304 G>A Gly668Asp
(N)
Neutral gyrA Quinolones Guillemin, Jarlier & Cambau (1998)
412280 T>G His481Gln Neutral iniA Ethambutol Ramaswamy et al. (2003)
575368 T>C Asp7Asp Rv0486 Isoniazid/Ethionamide Projahn et al. (2011)
763031 T>C Ala1081Ala rpoB Rifampicin Taniguchi et al. (1996)
763531 G>C Pro54Pro rpoC Rifampicin Comas et al. (2012)
763884 C>T Ala172Val Neutral rpoC Rifampicin Comas et al. (2012)
763886 C>A Arg173Arg rpoC Rifampicin Comas et al. (2012)
1406312 A>G His343His Rv1258c Streptomycin Siddiqi et al. (2004)
1417019 C>T Cys110Tyr Deleterious embR Ethambutol Ramaswamy et al. (2000)
1674162 C>T Gly241Gly fabG1 Isoniazid Lavender et al. (2005)
1792777 T>C Ile322Val Neutral Rv1592c Isoniazid Ramaswamy et al. (2003)
1792778 T>C Glu321Glu Rv1592c Isoniazid Ramaswamy et al. (2003)
2154724 C>A Arg463Leu Neutral katG Isoniazid Heym et al. (1995)
2518132 C>T Thr6Thr kasA Isoniazid Lee et al. (1999)
2519048 G>A Gly312Ser Neutral kasA Isoniazid Lee et al. (1999)
2521342 T>C Asp200Asp accD6 Isoniazid Ramaswamy et al. (2003)
3154414 A>G Ile73Thr Neutral efpA Isoniazid Ramaswamy et al. (2003)
3571834 T>G Gln237Pro Neutral nudC Isoniazid/Ethionamide Wang et al. (2011)
3647041 A>G Ser257Pro Neutral rmlD Ethambutol Ramaswamy et al. (2000)
3647591 A>G Asn73Asn rmlD Ethambutol Ramaswamy et al. (2000)
4049254 G>A Leu243Leu folP1 Para-aminosalicylic acid Mathys et al. (2009)
4240671 C>T Thr270Ile Neutral embC Ethambutol Ramaswamy et al. (2000)
4241042 A>G Asn394Asp Deleterious embC Ethambutol Ramaswamy et al. (2000)
4242643 C>T Arg927Arg embC Ethambutol Ramaswamy et al. (2000)
4243580 G>A Val116Val embA Ethambutol Telenti et al. (1997)
4244420 G>C Val396Val embA Ethambutol Telenti et al. (1997)
4245969 C>T Pro913Ser Deleterious embA Ethambutol Ramaswamy et al. (2000) and
Telenti et al. (1997)
4247578 G>A Leu355Leu embB Ethambutol Telenti et al. (1997)
4247646 A>C Glu378Ala Neutral embB Ethambutol Telenti et al. (1997)
4407588 T>C Ala205Ala rsmG Streptomycin Okamoto et al. (2007)
4407873 C>A Val110Val rsmG Streptomycin Okamoto et al. (2007)
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is a transcription regulator that belongs to AraC family. Its attenuation in a mouse model
resulted in an increased animal survival (Gupta, Jain & Tyagi, 1999; Singh et al., 2003). We
found mutation Leu316Arg in this gene in all isolates.
Stop codon was gained after Arg305 in PStA1, an inorganic phosphate ABC transporter.
Stop codon was however lost in Rv1504. The stop codon was replaced with glutamine as
codon 200. Rv1504 and PstA1 were reported to be involved in the adaptation and survival
of mycobacteria in macrophages (Brodin et al., 2010; Rengarajan, Bloom & Rubin, 2005).
Non-synonymous and synonymous SNPs were found in other genes involved in various
other functions related to virulence such as synthesis of complex and simple lipids, cell wall
proteins, lipoproteins, cholesterol metabolism, secretion systems, protein kinases, metal
transporter proteins, two component systems and other proteins of unknown functions
(Table S1).
Efflux pumps play roles in drug resistance, cell physiology, detoxification and virulence
of M. tuberculosis (Nikaido, 2009). Ten synonymous SNPs and 15 non-synonymous SNPs
were found in efflux pump related genes. One stop codonwas gained byRv2994, a predicted
transmembrane protein involved in efflux system (Table S2).
Twenty eight SNPs were observed in genes with known epitopes, 11 are synonymous
while 17 are non-synonymous (Table S3).
In addition, 316 SNPs were found in essential genes, 135 are synonymous, 181 are non-
synonymous. A start codon was lost in pabB gene. pabB is a cell membrane associated gene
that encodes para-aminobenzoate synthetase component-I involved in the biosynthesis
of p-aminobenzoate, a precursor of folate biosynthesis (Sassetti, Boyd & Rubin, 2003; Zheng
et al., 2008). The details of the position, nucleotide change, amino acid change and the
genes involved are presented in Table S4.
The association of the SNPs or deletions reported in this study to TBM needs further
investigations. This can be done by comparing them with variations from PTB cases, to
determine exclusive associations with TBM. Furthermore, The involvement of the reported
allelic changes in the functions of the various genes from which they were found can be
verified by site directedmutagenesis in laboratory strains ofM. tuberculosis, and subsequent
animal experiments.
CONCLUSION
Genetic factors that contribute to the ability of infecting mycobacteria in causing TBM
remain largely unknown. We have presented a detailed analysis of the polymorphism
existing in the genome of Nonthaburi isolates from TBM patients, when compared
to reference strain M. tuberculosis H37Rv (NC_000962.3). The polymorphisms were
compared to 1,601 genomes representing themembers of the 7MTBC lineages. Uniqueness
of certain SNPs to certain genotypes, countries or region such as found in this study may
be useful epidemiologically to determine the origin of an infection and potential level
of disease severity. We have also presented the first draft genomes of M. tuberculosis
Nonthaburi genotype.
Many studies have reported the SNPs playing roles in drug resistance in many drug-
resistant related genes. These have majorly formed the basis for the development of some
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databases. It is equally important to report polymorphisms found in these genes from drug
susceptible strains so that SNPs that are not involved in resistance to drugs but present
in the drug resistance related genes could be filtered out in the process of predicting
drug resistance. Our results will also form a basis for comparison with other genotypes of
mycobacteria isolated from the CSF of TBM or sputum of PTB patients in order to identify
potential factors contributing to TBM.
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